ICE Stock Chart & Stats
zł60.80
--
Market closed
zł60.80
--
Day’s Range― - ―
52-Week Rangezł10.14 - zł95.10
Previous CloseN/A
VolumeN/A
Average Volume (3M)26.26K
Market Cap
zł637.55M
Enterprise Valuezł680.75
Total Cash (Recent Filing)zł4.17M
Total Debt (Recent Filing)zł503.00K
Price to Earnings (P/E)―
Beta0.14
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding10,451,639
10 Day Avg. Volume44,694
30 Day Avg. Volume26,257
Financial Highlights & Ratios
PEG Ratio0.19
Price to Book (P/B)1.63
Price to Sales (P/S)0.00
P/FCF Ratio-12.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ICE FAQ
What was MediNice SA’s price range in the past 12 months?
MediNice SA lowest stock price was zł10.14 and its highest was zł95.10 in the past 12 months.
What is MediNice SA’s market cap?
MediNice SA’s market cap is zł637.55M.
When is MediNice SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were MediNice SA’s earnings last quarter?
Currently, no data Available
Is MediNice SA overvalued?
According to Wall Street analysts MediNice SA’s price is currently Overvalued.
Does MediNice SA pay dividends?
MediNice SA does not currently pay dividends.
What is MediNice SA’s EPS estimate?
MediNice SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MediNice SA have?
MediNice SA has 10,451,639 shares outstanding.
What happened to MediNice SA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of MediNice SA?
Currently, no hedge funds are holding shares in PL:ICE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
MediNice SA
Established in 2012 and headquartered in Warsaw, Poland, Medinice S.A. specializes in delivering advanced medical solutions for the fields of cardiology and cardiac surgery. The company actively assists scientists in the complex journey of bringing new products to market, offering comprehensive support that spans prototyping, conducting clinical trials, securing essential certifications, and overseeing product sales.
Technical Analysis
Biomaxima SA
―
Genomtec SA
―
Genomed S.A.
―
Medicofarma Biotech Spolka Akcyjna
―
Read-Gene SA
―
